ATE204286T1 - Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge - Google Patents

Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge

Info

Publication number
ATE204286T1
ATE204286T1 AT96917313T AT96917313T ATE204286T1 AT E204286 T1 ATE204286 T1 AT E204286T1 AT 96917313 T AT96917313 T AT 96917313T AT 96917313 T AT96917313 T AT 96917313T AT E204286 T1 ATE204286 T1 AT E204286T1
Authority
AT
Austria
Prior art keywords
glcp
alpha
analogues
modified
trisaccharide
Prior art date
Application number
AT96917313T
Other languages
English (en)
Inventor
Om Srivastava
Roman Szweda
Original Assignee
Alberta Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alberta Res Council filed Critical Alberta Res Council
Application granted granted Critical
Publication of ATE204286T1 publication Critical patent/ATE204286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96917313T 1995-06-07 1996-06-06 Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge ATE204286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/485,057 US5929037A (en) 1995-06-07 1995-06-07 Modified α-D-Glcρ-(1-2)-α-D-Glcρ-(1-3)-α-D-Glcρ-analogues
PCT/CA1996/000389 WO1996040700A1 (en) 1995-06-07 1996-06-06 MODIFIED α-D-Glcp-(1-2)-α-D-Glcp-(1-3)-α-D-Glcp-ANALOGUES

Publications (1)

Publication Number Publication Date
ATE204286T1 true ATE204286T1 (de) 2001-09-15

Family

ID=23926777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96917313T ATE204286T1 (de) 1995-06-07 1996-06-06 Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge

Country Status (7)

Country Link
US (1) US5929037A (de)
EP (1) EP0837867B1 (de)
AT (1) ATE204286T1 (de)
AU (1) AU5994696A (de)
CA (1) CA2158534A1 (de)
DE (1) DE69614552T2 (de)
WO (1) WO1996040700A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733692B2 (en) * 1997-02-28 2001-05-24 Regents Of The University Of California, The Inhibition of cell-cell binding by lipid assemblies
CN1394867A (zh) * 2001-07-06 2003-02-05 中国科学院生态环境研究中心 可作药物的寡糖和其制备方法及含该寡糖的药物组合物
ES2933616T3 (es) 2014-12-16 2023-02-10 Glycom As Separación de 2'-FL de un caldo de fermentación
EP4301765A4 (de) * 2021-03-03 2025-03-12 Emergent Product Development Gaithersburg Inc. Valiolaminderivate als glukosidaseinhibitoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173948A3 (de) * 1984-09-04 1987-11-04 Hoechst Aktiengesellschaft Neue Pseudooligosaccharide mit alpha-Glukosidase-hemmender Wirkung, Verfahren zur deren Herstellung, deren Verwendung und pharmazeutische Präparate
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
EP0422307A1 (de) * 1989-10-10 1991-04-17 Merrell Dow Pharmaceuticals Inc. Alpha-glukosidase-Schutzmittel
US5438124A (en) * 1991-07-16 1995-08-01 Health Research, Inc. Glycosylating reagent for the synthesis of linear and other α-L-fucosyl oligosaccharides

Also Published As

Publication number Publication date
WO1996040700A1 (en) 1996-12-19
DE69614552D1 (de) 2001-09-20
AU5994696A (en) 1996-12-30
EP0837867A1 (de) 1998-04-29
CA2158534A1 (en) 1996-12-08
DE69614552T2 (de) 2002-05-08
EP0837867B1 (de) 2001-08-16
US5929037A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
EP0599532A3 (de) Härtbare Einkomponenten-Organosiloxanzusammensetzungen.
ATE198143T1 (de) Zahnpasten
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
DE69016371D1 (de) Nitrotriazalon enthaltende gaserzeugende Zusammensetzungen.
ID28003A (id) Turunan-turunan adamantana
BR9205818A (pt) Composições azeotrópicas de 1,1,2,2-tetrafluororetano e semelhantes.
ES2195970T3 (es) L-ribavirina y usos de la misma.
EP0695171A1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
DE69106947D1 (de) Zyklodextrine enthaltende galenische Zusammensetzungen.
FR2712491B1 (fr) Compositions antisudorales.
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
DE69609652D1 (de) Stabilisator-enthaltende gaserzeugende Zusammensetzungen
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
DE69616074D1 (de) Ara-c derivate
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
BG100248A (bg) Инхибитори на скваленсинтетаза
DE69831737D1 (de) Neurotrypsin
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties